Highlights

  • Micro-X develops X-ray imaging systems using digitally controlled carbon nanotube emitters.
  • The NEX technology platform uses cold-cathode tubes instead of conventional heated-filament designs.
  • Its Rover Plus system supports mobile digital radiography in clinical settings.
  • A July 2026 update covered head CT imaging, full-body CT prototypes and ambulance integration work.
  • Product development involves engineering validation, regulatory requirements and commercial adoption.

Micro-X Ltd (ASX:MX1) develops and manufactures X-ray imaging technology for medical and security applications. Its proprietary NEX platform uses carbon nanotube emitters in cold-cathode X-ray tubes, allowing electronically controlled radiation generation without the heated filaments used by conventional systems. During 2026, the company continued working on portable computed tomography (CT) applications alongside its mobile digital radiography products. These activities link the underlying tube design with efforts to create more compact imaging equipment.

How Electronic Emission Changes X-Ray Equipment

Conventional X-ray tubes use heat to release electrons. Micro-X Ltd (ASX:MX1) instead uses carbon nanotube emitters that operate as cold cathodes, controlled through electronic systems. Its technology website describes NEX as a platform combining emitters with tailored tube designs for different imaging applications. This approach can reduce the size and weight of equipment, although actual clinical performance depends on the configuration of each finished device.

The technology is relevant to imaging systems that require multiple sources or precisely timed X-ray pulses. Micro-X Ltd (ASX:MX1) has described the use of solid-state generators and electronic tube switching in its CT development work. These are engineering features rather than proof of particular clinical outcomes. Any assessment of image quality, dose or diagnostic use requires evidence from the specific product and its applicable validation programme.

Rover Plus and Portable Radiography

Rover Plus is the company's mobile digital radiography system. Micro-X Ltd (ASX:MX1) markets it for applications requiring imaging equipment to move within healthcare facilities. The product information describes a system weighing approximately 105 kg, with a compact design intended to assist manoeuvrability. Its medical applications differ from the proposed CT programmes: digital radiography generally captures projection images, whereas CT reconstructs cross-sectional views from multiple measurements.

For hospitals, the operational proposition concerns portability, positioning and equipment integration into clinical workflows. Practical use also depends on training, maintenance and imaging protocols.

2026 CT Engineering Milestones

In a July 2026 investor newsletter, Micro-X Ltd (ASX:MX1) described its head CT human-imaging study, portable full-body CT development and new lung CT research. The company also reported completion of a design-release review and manufacture of early prototype components under an ambulance-related grant milestone. The next engineering activity described at that time involved integrating the scanner design with an ambulance platform and preparing for a vehicle-fitment review.

The same update stated that construction of its first full-body CT prototype was underway. It was based on a series of existing X-ray tubes and a solid-state generator adapted for switching between tubes. Micro-X Ltd (ASX:MX1) characterised this as an initial phase of its work under a US government healthcare research programme. A prototype represents development progress; it is not equivalent to a cleared, commercially deployed medical device.

Commercial and Regulatory Considerations

The company's technology serves several potential product types, but each has distinct development, manufacturing and regulatory requirements. For Micro-X Ltd (ASX:MX1), moving from component demonstrations to repeatable production involves emitter reliability, consistent image generation, system integration and quality assurance. Clinical imaging applications also require appropriate assessments and approvals before use in their intended markets.

Product rollouts remain subject to testing, regulatory status and customer adoption.

Key Insights

Micro-X Ltd (ASX:MX1) is applying one carbon nanotube-based technology platform to mobile radiography and several CT development programmes. Its 2026 disclosures establish progress on engineering prototypes and imaging research, while leaving subsequent testing, regulatory and commercial milestones to be assessed separately. The distinction between existing products and systems still being developed is central to understanding its activities.